Innovating Rare Disease Treatment: Integrating Digital Tools from Day One

How pharma, advocacy groups, and digital platforms are revolutionizing patient support

In this webinar, UCB Pharma and the Les Turner ALS Foundation joined Medisafe discuss the integration of digital tools in innovating rare disease treatment. Below are the highlights and the full webinar:

  • The integration of digital tools in rare disease treatment can significantly streamline diagnosis and therapy initiation, offering a more personalized approach to patient care.
  • Multidisciplinary care is vital for ALS patients, involving various specialists like neurologists, pulmonologists, and occupational therapists to enhance quality of life and extend survival.
  • Patient engagement and the use of hyper-personalized digital tools can improve adherence, engagement, and ultimately patient outcomes in rare diseases.



You may also like

How AI Can Help Make HCPs “More Human”

Emre Ozcan, PhD, SVP, Head of Global Digital Health, Merck KGaA Darmstadt Germany and Omri Shor, CEO and Founder, Medisafe 

..Read More
Webinars

Innovating Rare Disease Treatment: Integrating Digital Tools from Day One

In this webinar, UCB Pharma and the Les Turner ALS Foundation joined Medisafe discuss the integration of digital tools in 

..Read More

Medisafe Launches PATHWAYS: A New Tool to Help Manage the Patient Journey

BOSTON, MA / ACCESS Newswire / February 13, 2025 / Medisafe, the leading digital health and patient engagement platform, is proud to announce 

..Read More

Want to Learn More?

We bring decades of experience to your challenges—and technology and solutions uniquely designed to meet your needs.